Nahomi Tokudome

1.9k total citations
52 papers, 1.2k citations indexed

About

Nahomi Tokudome is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Nahomi Tokudome has authored 52 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Oncology, 20 papers in Pulmonary and Respiratory Medicine and 13 papers in Cancer Research. Recurrent topics in Nahomi Tokudome's work include Cancer Treatment and Pharmacology (13 papers), Cancer Cells and Metastasis (12 papers) and HER2/EGFR in Cancer Research (12 papers). Nahomi Tokudome is often cited by papers focused on Cancer Treatment and Pharmacology (13 papers), Cancer Cells and Metastasis (12 papers) and HER2/EGFR in Cancer Research (12 papers). Nahomi Tokudome collaborates with scholars based in Japan, United States and India. Nahomi Tokudome's co-authors include Nobuyuki Yamamoto, Yasuhiro Koh, Hiroaki Akamatsu, Atsushi Hayata, Masanori Nakanishi, Hiroki Ueda, Keiichiro Akamatsu, Yoshinori Ito, Kuninobu Kanai and Koichi Sato and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Nahomi Tokudome

45 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nahomi Tokudome Japan 18 980 422 374 206 108 52 1.2k
Zishuo I. Hu United States 11 748 0.8× 378 0.9× 415 1.1× 217 1.1× 197 1.8× 12 1.2k
Julia Jückstöck Germany 17 969 1.0× 305 0.7× 698 1.9× 356 1.7× 88 0.8× 38 1.3k
Robert A. Somer United States 15 946 1.0× 417 1.0× 220 0.6× 215 1.0× 255 2.4× 34 1.3k
Françoise Drusch France 14 544 0.6× 195 0.5× 305 0.8× 215 1.0× 137 1.3× 17 924
Antonio Cubillo Spain 18 864 0.9× 253 0.6× 233 0.6× 208 1.0× 118 1.1× 88 1.1k
Alejandro Avilés‐Salas Mexico 14 369 0.4× 249 0.6× 186 0.5× 295 1.4× 81 0.8× 62 768
N. Al-Sakaff Switzerland 11 901 0.9× 357 0.8× 320 0.9× 163 0.8× 79 0.7× 27 1.2k
Marta Santisteban Spain 16 582 0.6× 134 0.3× 264 0.7× 308 1.5× 161 1.5× 55 957
Zhanhong Xie China 18 761 0.8× 519 1.2× 172 0.5× 227 1.1× 164 1.5× 60 1.1k
Gabriele Gamerith Austria 18 507 0.5× 200 0.5× 193 0.5× 233 1.1× 178 1.6× 44 914

Countries citing papers authored by Nahomi Tokudome

Since Specialization
Citations

This map shows the geographic impact of Nahomi Tokudome's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nahomi Tokudome with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nahomi Tokudome more than expected).

Fields of papers citing papers by Nahomi Tokudome

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nahomi Tokudome. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nahomi Tokudome. The network helps show where Nahomi Tokudome may publish in the future.

Co-authorship network of co-authors of Nahomi Tokudome

This figure shows the co-authorship network connecting the top 25 collaborators of Nahomi Tokudome. A scholar is included among the top collaborators of Nahomi Tokudome based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nahomi Tokudome. Nahomi Tokudome is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Akamatsu, Hiroaki, Shunsuke Teraoka, Masanori Tanaka, et al.. (2023). A Phase II Study of High-Flow Nasal Cannula for Relieving Dyspnea in Advanced Cancer Patients. Journal of Pain and Symptom Management. 67(3). 204–211.e1. 3 indexed citations
2.
Sato, Koichi, Hiroaki Akamatsu, Eriko Murakami, et al.. (2017). Correlation between immune-related adverse events and efficacy in non-small cell lung cancer treated with nivolumab. Annals of Oncology. 28. ix86–ix86. 41 indexed citations
3.
Koh, Yasuhiro, Hiroaki Akamatsu, Kuninobu Kanai, et al.. (2017). Development of an automated size-based filtration system for isolation of circulating tumor cells in lung cancer patients. PLoS ONE. 12(6). e0179744–e0179744. 36 indexed citations
4.
Tokudome, Nahomi, Hiroki Ueda, Masanori Nakanishi, et al.. (2016). Detection and management of everolimus associated pneumonitis with serum markers for interstitial pneumonia. Annals of Oncology. 27. vii101–vii101.
5.
Paoletti, Costanza, Maria C. Muñiz, Dafydd G. Thomas, et al.. (2014). Development of Circulating Tumor Cell-Endocrine Therapy Index in Patients with Hormone Receptor–Positive Breast Cancer. Clinical Cancer Research. 21(11). 2487–2498. 104 indexed citations
6.
Sawaki, Masataka, Nahomi Tokudome, Toshiro Mizuno, et al.. (2011). Evaluation of Trastuzumab Without Chemotherapy as a Post-operative Adjuvant Therapy in HER2-positive Elderly Breast Cancer Patients: Randomized Controlled Trial [RESPECT (N-SAS BC07)]. Japanese Journal of Clinical Oncology. 41(5). 709–712. 33 indexed citations
7.
Tokudome, Nahomi, Yoshinori Ito, Shunji Takahashi, et al.. (2011). Detection of circulating tumor cells in peripheral blood of heavily treated metastatic breast cancer patients. Breast Cancer. 18(3). 195–202. 13 indexed citations
8.
Sawaki, Masataka, Hirofumi Mukai, Nahomi Tokudome, et al.. (2011). Safety of adjuvant trastuzumab for HER-2-overexpressing elderly breast cancer patients: a multicenter cohort study. Breast Cancer. 19(3). 253–258. 11 indexed citations
9.
Ito, Yoshinori, Chie Watanabe, Kotaro Iijima, et al.. (2011). Incidence of chemotherapy-induced amenorrhea in premenopausal patients with breast cancer following adjuvant anthracycline and taxane. Breast Cancer. 18(3). 182–188. 29 indexed citations
10.
Ito, Yoshinori, Koichi Nagasaki, Yoshio Miki, et al.. (2010). Prospective randomized phase II study determines the clinical usefulness of genetic biomarkers for sensitivity to primary chemotherapy with paclitaxel in breast cancer. Cancer Science. 102(1). 130–136. 2 indexed citations
11.
Tokudome, Nahomi, Yoshinori Ito, Kiyohiko Hatake, et al.. (2008). Trastuzumab and vinorelbine as first-line therapy for HER2-overexpressing metastatic breast cancer: multicenter phase II and pharmacokinetic study in Japan. Anti-Cancer Drugs. 19(7). 753–759. 8 indexed citations
12.
Osako, Tomo, Yoshinori Ito, Shunji Takahashi, et al.. (2007). Efficacy and safety of trastuzumab plus capecitabine in heavily pretreated patients with HER2-positive metastatic breast cancer. Cancer Chemotherapy and Pharmacology. 62(1). 159–164. 10 indexed citations
13.
Hatake, Kiyohiko, Nahomi Tokudome, & Yoshinori Ito. (2007). 5. Tanstuzumab Treatment for Breast Cancer. Internal Medicine. 46(3). 149–150. 3 indexed citations
14.
Hatake, Kiyohiko, Nahomi Tokudome, & Yoshinori Ito. (2007). Next generation molecular targeted agents for breast cancer: focus on EGFR and VEGFR pathways. Breast Cancer. 14(2). 132–149. 21 indexed citations
15.
Ito, Yoshinori & Nahomi Tokudome. (2006). [Chemotherapy for metastatic breast cancer].. PubMed. 33(6). 742–6. 2 indexed citations
16.
Tokudome, Nahomi & Yoshinori Ito. (2006). [Adjuvant chemotherapy based on evidence-based medicine for breast cancer patients].. PubMed. 33(3). 318–23. 3 indexed citations
17.
Sawaki, Masataka, Yoshinori Ito, Futoshi Akiyama, et al.. (2006). High prevalence of HER-2/neu and p53 overexpression in inflammatory breast cancer. Breast Cancer. 13(2). 172–178. 47 indexed citations
18.
Tokudome, Nahomi, Hiroshi Sakuma, Seiichiro Nishimura, et al.. (2005). . Nihon Nyugan Kenshin Gakkaishi (Journal of Japan Association of Breast Cancer Screening). 14(1). 86–89.
19.
Nishimura, Seiichiro, Masahiko Tanabe, Nahomi Tokudome, et al.. (2003). . Nihon Nyugan Kenshin Gakkaishi (Journal of Japan Association of Breast Cancer Screening). 12(1). 44–49. 1 indexed citations
20.
Tokudome, Nahomi, Koki Tanaka, Masahiro Kai, et al.. (2002). Primitive neuroectodermal tumor of the transverse colonic mesentery defined by the presence of EWS-FLI1 chimeric mRNA in a Japanese woman. Journal of Gastroenterology. 37(7). 543–549. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zishuo I. Hu Breakdown of academic impact, for papers by Julia Jückstöck Breakdown of academic impact, for papers by Robert A. Somer Breakdown of academic impact, for papers by Françoise Drusch Breakdown of academic impact, for papers by Antonio Cubillo Breakdown of academic impact, for papers by Alejandro Avilés‐Salas Breakdown of academic impact, for papers by N. Al-Sakaff Breakdown of academic impact, for papers by Marta Santisteban Breakdown of academic impact, for papers by Zhanhong Xie Breakdown of academic impact, for papers by Gabriele Gamerith
Rankless by CCL
2026